These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 2725474

  • 1. Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors.
    Potter LT, Ferrendelli CA, Hanchett HE, Hollifield MA, Lorenzi MV.
    Mol Pharmacol; 1989 May; 35(5):652-60. PubMed ID: 2725474
    [Abstract] [Full Text] [Related]

  • 2. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
    Flynn DD, Mash DC.
    J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841
    [Abstract] [Full Text] [Related]

  • 3. Effects of tetrahydroaminoacridine on M1 and M2 muscarine receptors.
    Pearce BD, Potter LT.
    Neurosci Lett; 1988 Jun 07; 88(3):281-5. PubMed ID: 3386874
    [Abstract] [Full Text] [Related]

  • 4. Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors.
    Flynn DD, Vaishnav AA, Mash DC.
    Mol Pharmacol; 1992 Apr 07; 41(4):736-42. PubMed ID: 1569924
    [Abstract] [Full Text] [Related]

  • 5. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
    Lazareno S, Buckley NJ, Roberts FF.
    Mol Pharmacol; 1990 Dec 07; 38(6):805-15. PubMed ID: 2250662
    [Abstract] [Full Text] [Related]

  • 6. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul 07; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 7. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
    Kenakin T, Boselli C.
    J Pharmacol Exp Ther; 1989 Sep 07; 250(3):944-52. PubMed ID: 2778720
    [Abstract] [Full Text] [Related]

  • 8. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M, Waelbroeck M, Christophe J.
    Mol Pharmacol; 1987 Jul 07; 32(1):100-8. PubMed ID: 3600611
    [Abstract] [Full Text] [Related]

  • 9. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
    Jakubík J, Bacáková L, el-Fakahany EE, Tucek S.
    J Pharmacol Exp Ther; 1995 Sep 07; 274(3):1077-83. PubMed ID: 7562472
    [Abstract] [Full Text] [Related]

  • 10. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart.
    Wang JX, Mei L, Yamamura HI, Roeske WR.
    J Pharmacol Exp Ther; 1987 Sep 07; 242(3):981-90. PubMed ID: 3116203
    [Abstract] [Full Text] [Related]

  • 11. Assessment of the allosteric interactions of the bisquaternary heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at M1 and M2 muscarine receptors.
    Christopoulos A, Mitchelson F.
    Mol Pharmacol; 1994 Jul 07; 46(1):105-14. PubMed ID: 8058045
    [Abstract] [Full Text] [Related]

  • 12. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH, el-Fakahany EE.
    J Pharmacol Exp Ther; 1985 Jun 07; 233(3):707-14. PubMed ID: 3839264
    [Abstract] [Full Text] [Related]

  • 13. Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes.
    Lee NH, el-Fakahany EE.
    J Pharmacol Exp Ther; 1991 Feb 07; 256(2):468-79. PubMed ID: 1993991
    [Abstract] [Full Text] [Related]

  • 14. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1986 May 07; 237(2):419-27. PubMed ID: 3754581
    [Abstract] [Full Text] [Related]

  • 15. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.
    Hu J, Wang SZ, Forray C, el-Fakahany EE.
    Mol Pharmacol; 1992 Aug 07; 42(2):311-21. PubMed ID: 1513329
    [Abstract] [Full Text] [Related]

  • 16. Stabilization of antagonist binding to cardiac muscarinic acetylcholine receptors by gallamine and other neuromuscular blocking drugs.
    Nedoma J, Tucek S, Danilov AF, Shelkovnikov SA.
    J Pharmacol Exp Ther; 1986 Jan 07; 236(1):219-23. PubMed ID: 3941394
    [Abstract] [Full Text] [Related]

  • 17. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
    McKinney M, Stenstrom S, Richelson E.
    Mol Pharmacol; 1985 Feb 07; 27(2):223-35. PubMed ID: 2982089
    [Abstract] [Full Text] [Related]

  • 18. Evidence of paired M2 muscarinic receptors.
    Potter LT, Ballesteros LA, Bichajian LH, Ferrendelli CA, Fisher A, Hanchett HE, Zhang R.
    Mol Pharmacol; 1991 Feb 07; 39(2):211-21. PubMed ID: 1899905
    [Abstract] [Full Text] [Related]

  • 19. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
    Dunlap J, Brown JH.
    Mol Pharmacol; 1983 Jul 07; 24(1):15-22. PubMed ID: 6135150
    [Abstract] [Full Text] [Related]

  • 20. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH, el-Fakahany EE.
    J Pharmacol Exp Ther; 1988 Sep 07; 246(3):829-38. PubMed ID: 3418516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.